课题基金 / 基金详情

Analysis on the activated T-cells in lymphoproliferative diseases

Analysis on the activated T-cells in lymphoproliferative diseases
淋巴细胞增殖性疾病中活化的 T 细胞分析
批准号:
13670814
负责人:
OHGA Shouichi
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

OHGA Shouichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lymphoproliferative disease (LPD) is defined as a clonal disorder of lymphocytes without histopathological evidence of malignancy. Epstein-Barr virus (EBV) is reactivated and associated with the development of B-cell LPD in immunodeficient patients. This virus infects T/NK cells in immunocompetent subjects and induces EBV^+ T-cell LPD including chronic active EBV infection (CAEBV) and hemophagocytic lymphohistiocytosis (HLH). On the other hand, there is a group of inherited LPD caused by the defective functional molecule of T cells. Patients with primary HLH or autoimmune lymphoproliferative syndrome (ALPS) show hypercytokinemia or autoimmunity, because the cytotoxcity and activation-induced cell death (AICD) are impaired by the defects of perforin and Fas, respectively. Hyper-IgE syndrome (HIES) is a congenital immunodeficiency characterized by recurrent infections, marked IgE elevation, and increase of activated T cells. The defective IFNγ production is implicated in the pathogenesis … More of HIES. The present study revealed that the cytokines released from persistently activated T cells could contribute to the pathophysiology of these diseases.1) primary HLH: Perforin gene defects were found in 2/8 Japansese patients with familial HLH (FHL), and 1/7 patients without affected siblings (4 novel mutations). The protein was not expressed in CD8^+/CD56^+ cells of the patient. The frequency of mutation was 〜20% of FHL in Japan.2) ALPS: Patients with CD4^-CD8^- double negative (DN) αβT-cell expansion showed high serum IL-10 levels. IL-10-expressing DNT cells were increased in patients with lymphoproliferation. Real-time PCR revealed 〜100 times higher IL-10, but not, IFNγ or TGFβ in DN than in single positive T-cells. IL-10 was exclusively expressed in DN αβ but not γδ-cells. Circulating DN αβT-cells may constitutively express IL-10 and contribute to the ALPS phenotype.3) HIES: Cytokine profile of HLA-DR^+ and DR^- T-cells was analyzed. IFNγ/IL-4 or IFNγ/IL-10 ratio in DR^+ T-cells of HIES was lower than each of chronic granulomatous disease (CGD). TGFβ/IL-4 ratio in DR^+ T-cells of HIES was lower than that of atopy or CGD. TGFβ/IL-4 in DR^- T-cells of HIES was also lower than that of atopy. The statistical analysis revealed that TGFβ/IL-4 ratios in DR^+ or DR^- T-cells were the most powerful parameters to distinguish HIES from atopy and/or CGD. The in vivo activated T-cells of HIES might not sufficiently express IFNγ and TGFβ genes to counteract on the IL-4 dependent IgE production. The reduced TGFβ expression may imply the indigenous T-cell defects of HIES. Less
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
Ishizaki Y, et al.: "Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella"J Infect. (in press).
Ishizaki Y 等人:“循环水痘带状疱疹病毒 DNA 的定量用于内脏水痘的早期诊断”J Infect。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohga S, Nomura A, Takahata Y, Ihara K, Takada H, Wakiguchi H, Kudo Y, Hara T:: "Dominant expression of IL-10 but not IFN-γ in CD4^- CD8^- αβ T cells of autoimmune lymphoproliferative syndrome."Br J Haematol. 119. 535-538 (2002)
Ohga S、Nomura A、Takahata Y、Ihara K、Takada H、Wakiguchi H、Kudo Y、Hara T::“自身免疫性淋巴细胞增殖性 CD4^- CD8^- αβ T 细胞中 IL-10 的显性表达,而非 IFN-γ 的显性表达综合征。”Br J Haematol. 119. 535-538 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kogawa K, Kudoh J, Nagafuchi S, Katsuta H, Ohga S, et al.: "Phenotype of autoimmune polyglandular syndrome type I and genotype of AIRE gene in a Japanese family"Clinical Immunology. 103. 277-283 (2002)
Kokawa K,Kudoh J,Nagafuchi S,Katsuta H,Ohga S,等:“日本家族中自身免疫性多腺体综合征 I 型表型和 AIRE 基因的基因型”临床免疫学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takada H, Nomura A, Ohga S, Hara T: "IL-18 in hemophagocytic lymphohistiocytosis"Leukemia and Lymphoma. 42. 21-28 (2001)
Takada H、Nomura A、Ohga S、Hara T:“噬血细胞性淋巴组织细胞增多症中的 IL-18”白血病和淋巴瘤。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
42
    Research on the pathogenesis and treatment of Epstein-Barr virusassociated intractable diseases
    • 批准号:
      21591388
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      OHGA Shouichi
    • 依托单位:
    Therapeutic strategy and biological characterization of Epstein-Barr virus (EBV) infected cells in chronic active EBV infection
    • 批准号:
      19591255
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      OHGA Shouichi
    • 依托单位:
    Analysis of pathogenesis and pathophysiology of congenital bone marrow failure for the establishment of the treatment strategy
    • 批准号:
      15591114
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2003
    • 负责人:
      OHGA Shouichi
    • 依托单位:
    T-cell analysis on chronic active Epstein-Barr virus (EBV) infection and EBV-associated lymphoproliferative diseases
    • 批准号:
      11670766
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      1999
    • 负责人:
      OHGA Shouichi
    • 依托单位:
    国内基金
    海外基金
    孔道形成蛋白perforin-2通过介导抗原提呈促进体液免疫的功能及机制研究
    • 批准号:
      --
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      34万元
    • 批准年份:
      2022
    • 负责人:
      邓成捷
    • 依托单位:
    Tim-3信号通路异常调控uNK细胞分泌perforin影响反复着床失败患者子宫内膜容受性的分子机制
    • 批准号:
      81771656
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2017
    • 负责人:
      徐步芳
    • 依托单位:
    H2A-Perforin融合蛋白对小鼠肝移植后免疫反应性的影响及机制
    重组人抗Tac-Perforin免疫毒素的研制
    • 批准号:
      39200045
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      5.0万元
    • 批准年份:
      1992
    • 负责人:
      王一理
    • 依托单位: